Cargando…

Overexpression of PrPc, combined with MGr1-Ag/37LRP, is predictive of poor prognosis in gastric cancer

Prion protein (PrPc) has been previously reported to be involved in gastric cancer (GC) development and progression. However, the association between expression of PrPc and GC prognosis is yet poorly characterized. In the present study, the expressions of PrPc and MGr1-Ag/37LRP, a protein interactin...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Lin, Shang, Yulong, Liu, Changhao, Li, Jinge, Hu, Hao, Liang, Cong, Han, Yanan, Zhang, Wei, Liang, Jie, Wu, Kaichun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4277329/
https://www.ncbi.nlm.nih.gov/pubmed/24706505
http://dx.doi.org/10.1002/ijc.28883
_version_ 1782350377287417856
author Zhou, Lin
Shang, Yulong
Liu, Changhao
Li, Jinge
Hu, Hao
Liang, Cong
Han, Yanan
Zhang, Wei
Liang, Jie
Wu, Kaichun
author_facet Zhou, Lin
Shang, Yulong
Liu, Changhao
Li, Jinge
Hu, Hao
Liang, Cong
Han, Yanan
Zhang, Wei
Liang, Jie
Wu, Kaichun
author_sort Zhou, Lin
collection PubMed
description Prion protein (PrPc) has been previously reported to be involved in gastric cancer (GC) development and progression. However, the association between expression of PrPc and GC prognosis is yet poorly characterized. In the present study, the expressions of PrPc and MGr1-Ag/37LRP, a protein interacting with PrPc, were detected using the tissue microarray technique and immunohistochemical method to compare clinicopathological parameters of 238 GC patients. We found that the expressions of PrPc and MGr1-Ag/37LRP were upregulated in GC lesions compared with their expressions in adjacent noncancerous tissues (p < 0.01). High expression of PrPc was detected in 37.39% (89/238) of GC patients and positively correlated with the expression of MGr1-Ag/37LRP (r = 0.532, p < 0.001). PrPc expression was associated with a number of clinicopathological parameters including depth of invasion and lymph node metastasis of the tumor (p < 0.001). High expression of PrPc brought a poorer prognosis than low PrPc expression. Moreover, GC patients with high level of PrPc and high level of MGr1-Ag/37LRP had the poorest prognosis. Multivariate survival analysis suggested that, along with other parameters, combined expression of PrPc and MGr1-Ag/37LRP was independent prognostic factors for GC patients. These data indicates that overexpression of PrPc, combined with MGr1-Ag/37LRP, is predictive of poor prognosis in GC and thereby could be used to guide the clinical decision. WHAT'S NEW? Prion protein was originally exclusively associated with prion disease but has now been linked to other processes such as cancer and inflammation. Here the authors examined the role of prion protein and its receptor MGr1-Ag/37LRP in gastric cancer. They found that both factors were upregulated in gastric cancer, and not in neighboring healthy, tissues and established the combined expression of prion protein and MGr1-Ag/37LRP as an independent prognostic factor for gastric cancer patients. These studies support a new role of prion protein in cancer and identify a new biomarker for a more accurate prediction of prognosis in gastric cancer patients.
format Online
Article
Text
id pubmed-4277329
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BlackWell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-42773292014-12-29 Overexpression of PrPc, combined with MGr1-Ag/37LRP, is predictive of poor prognosis in gastric cancer Zhou, Lin Shang, Yulong Liu, Changhao Li, Jinge Hu, Hao Liang, Cong Han, Yanan Zhang, Wei Liang, Jie Wu, Kaichun Int J Cancer Cancer Cell Biology Prion protein (PrPc) has been previously reported to be involved in gastric cancer (GC) development and progression. However, the association between expression of PrPc and GC prognosis is yet poorly characterized. In the present study, the expressions of PrPc and MGr1-Ag/37LRP, a protein interacting with PrPc, were detected using the tissue microarray technique and immunohistochemical method to compare clinicopathological parameters of 238 GC patients. We found that the expressions of PrPc and MGr1-Ag/37LRP were upregulated in GC lesions compared with their expressions in adjacent noncancerous tissues (p < 0.01). High expression of PrPc was detected in 37.39% (89/238) of GC patients and positively correlated with the expression of MGr1-Ag/37LRP (r = 0.532, p < 0.001). PrPc expression was associated with a number of clinicopathological parameters including depth of invasion and lymph node metastasis of the tumor (p < 0.001). High expression of PrPc brought a poorer prognosis than low PrPc expression. Moreover, GC patients with high level of PrPc and high level of MGr1-Ag/37LRP had the poorest prognosis. Multivariate survival analysis suggested that, along with other parameters, combined expression of PrPc and MGr1-Ag/37LRP was independent prognostic factors for GC patients. These data indicates that overexpression of PrPc, combined with MGr1-Ag/37LRP, is predictive of poor prognosis in GC and thereby could be used to guide the clinical decision. WHAT'S NEW? Prion protein was originally exclusively associated with prion disease but has now been linked to other processes such as cancer and inflammation. Here the authors examined the role of prion protein and its receptor MGr1-Ag/37LRP in gastric cancer. They found that both factors were upregulated in gastric cancer, and not in neighboring healthy, tissues and established the combined expression of prion protein and MGr1-Ag/37LRP as an independent prognostic factor for gastric cancer patients. These studies support a new role of prion protein in cancer and identify a new biomarker for a more accurate prediction of prognosis in gastric cancer patients. BlackWell Publishing Ltd 2014-11-15 2014-04-17 /pmc/articles/PMC4277329/ /pubmed/24706505 http://dx.doi.org/10.1002/ijc.28883 Text en © 2014 The Authors. Published by Wiley Periodicals, Inc. on behalf of UICC http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Cancer Cell Biology
Zhou, Lin
Shang, Yulong
Liu, Changhao
Li, Jinge
Hu, Hao
Liang, Cong
Han, Yanan
Zhang, Wei
Liang, Jie
Wu, Kaichun
Overexpression of PrPc, combined with MGr1-Ag/37LRP, is predictive of poor prognosis in gastric cancer
title Overexpression of PrPc, combined with MGr1-Ag/37LRP, is predictive of poor prognosis in gastric cancer
title_full Overexpression of PrPc, combined with MGr1-Ag/37LRP, is predictive of poor prognosis in gastric cancer
title_fullStr Overexpression of PrPc, combined with MGr1-Ag/37LRP, is predictive of poor prognosis in gastric cancer
title_full_unstemmed Overexpression of PrPc, combined with MGr1-Ag/37LRP, is predictive of poor prognosis in gastric cancer
title_short Overexpression of PrPc, combined with MGr1-Ag/37LRP, is predictive of poor prognosis in gastric cancer
title_sort overexpression of prpc, combined with mgr1-ag/37lrp, is predictive of poor prognosis in gastric cancer
topic Cancer Cell Biology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4277329/
https://www.ncbi.nlm.nih.gov/pubmed/24706505
http://dx.doi.org/10.1002/ijc.28883
work_keys_str_mv AT zhoulin overexpressionofprpccombinedwithmgr1ag37lrpispredictiveofpoorprognosisingastriccancer
AT shangyulong overexpressionofprpccombinedwithmgr1ag37lrpispredictiveofpoorprognosisingastriccancer
AT liuchanghao overexpressionofprpccombinedwithmgr1ag37lrpispredictiveofpoorprognosisingastriccancer
AT lijinge overexpressionofprpccombinedwithmgr1ag37lrpispredictiveofpoorprognosisingastriccancer
AT huhao overexpressionofprpccombinedwithmgr1ag37lrpispredictiveofpoorprognosisingastriccancer
AT liangcong overexpressionofprpccombinedwithmgr1ag37lrpispredictiveofpoorprognosisingastriccancer
AT hanyanan overexpressionofprpccombinedwithmgr1ag37lrpispredictiveofpoorprognosisingastriccancer
AT zhangwei overexpressionofprpccombinedwithmgr1ag37lrpispredictiveofpoorprognosisingastriccancer
AT liangjie overexpressionofprpccombinedwithmgr1ag37lrpispredictiveofpoorprognosisingastriccancer
AT wukaichun overexpressionofprpccombinedwithmgr1ag37lrpispredictiveofpoorprognosisingastriccancer